Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.50 |
| ▸ | AR | P10275 | 1/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
| ▸ | BRAF | P15056 | 2/20 | 0.39 |
| ▸ | DAO | P14920 | 2/20 | 0.38 |
| ▸ | METAP2 | P50579 | 1/20 | 0.38 |
| ▸ | PARP15 | Q460N3 | 5/20 | 0.38 |
| ▸ | PARP10 | Q53GL7 | 4/20 | 0.38 |
| ▸ | SLC18A1 | P54219 | 1/20 | 0.37 |
| ▸ | SLC18A2 | Q05940 | 1/20 | 0.37 |
| ▸ | AURKA | O14965 | 1/20 | 0.36 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3277310 | 0.79 | HSD17B10 (0.46) | KDM4EHSD17B10BRAFDAOMETAP2 | |
| SCHEMBL438637 | 0.79 | AR (0.47) | KDM4EARHSD17B10BRAFPARP15 | |
| SCHEMBL8691865 | 0.76 | KDM4E (0.43) | KDM4EHSD17B10BRAFDAOMETAP2 | |
| SCHEMBL17142230 | 0.76 | KDM4E (0.43) | KDM4EARHSD17B10BRAFDAO | |
| SCHEMBL7072330 | 0.75 | BRAF (0.58) | KDM4EARHSD17B10BRAFAURKA | |
| SCHEMBL6953743 | 0.72 | PIK3CD (0.40) | KDM4EHSD17B10BRAFDAOMETAP2 | |
| SCHEMBL3069941 | 0.72 | PIK3CD (0.47) | KDM4EARHSD17B10DAOPARP15 | |
| SCHEMBL10489398 | 0.72 | HSD17B10 (0.40) | KDM4EHSD17B10BRAFDAOMETAP2 | |
| SCHEMBL2462837 | 0.71 | KDM4E (0.55) | KDM4EHSD17B10DAOMETAP2PARP15 | |
| SCHEMBL11347457 | 0.71 | KDM4E (0.50) | KDM4EHSD17B10DAOMETAP2PARP15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1315497-A2 | AMINO DERIVATIVES OF 2,3-DIHYDROPHTALAZINE-1,4-DIONE AS IMMUNOCORRECTING AGENTS | Medinkor ZMM AG (CH) | 2003-06-04 | — | — | EP | claimed |
| WO-2002009681-A2 | A METHOD FOR CORRECTING THE IMMUNE SYSTEM OF LIVE BODY | MEDINKOR ZMM AG (CH) | 2002-02-07 | — | — | WO | claimed |
| US-20030195183-A1 | Method for correcting immune system of live body | ZHILOV VALERII KHAZHUMURATOVIC (RU) | 2003-10-16 | — | — | US | disclosed |
| EP-1315497-A2 | AMINO DERIVATIVES OF 2,3-DIHYDROPHTALAZINE-1,4-DIONE AS IMMUNOCORRECTING AGENTS | Medinkor ZMM AG (CH) | 2003-06-04 | — | — | EP | disclosed |
| WO-2002009681-A2 | A METHOD FOR CORRECTING THE IMMUNE SYSTEM OF LIVE BODY | MEDINKOR ZMM AG (CH) | 2002-02-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030195183-A1 | Method for correcting immune system of live body | IL15, IL5, IL2 | KDM4E 823/4885AR 3524/4885HSD17B10 792/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.